Nitric Oxide Colorimetric Assay Kit




Catalog#: K262-200 | Size: 200 assays



負責Sales: 許虹宜0920-312382

原廠網站: www.biovision.com


公司網站: www.biopioneer.com.tw


Kit Summary:
• Detection method- Absorbance (540 nm)
• Sample type- Cell and Tissue lysates, culture media, urine, plasma and serum, as well as many other biological fluids
• Species reactivity- Mammalian
• Applications- BioVision’s Nitric Oxide Colorimetric Assay Kit provides an accurate, convenient measure of total nitrate/nitrite in a simple two-step process.


Features & Benefits:
• Simple two-step procedure; takes only ~1-1.5 hours
• Fast and convenient
• BioVision’s Nitric Oxide Colorimetric Assay Kit provides an accurate, convenient measure of total nitrate/nitrite.


Kit components:
• Assay Buffer
• Enzyme cofactor
• Enhancer
• Nitrate Reductase
• Nitrate Standard
• Nitrite Standard
• Griess Reagent R1
• Griess Reagent R2
• Microtiter Plate
• Plate Cover


Description:
Nitric oxide (NO) plays an important role in neurotransmission, vascular regulation, immune response and apoptosis. NO is rapidly oxidized to nitrite and nitrate which are used to quantitate NO production. BioVision’s Nitric Oxide Colorimetric Assay Kit provides an accurate, convenient measure of total nitrate/nitrite in a simple two-step process. The first step converts nitrate to nitrite utilizing nitrate reductase. The second step uses Griess Reagents to convert nitrite to a deep purple azo compound. The amount of the azochromophore accurately reflects nitric oxide amount in samples. The detection limit of the assay is approximately 0.1 nmole nitrite/well, or 1 µM.


Storage Conditions:
-20°C


Shipping Conditions:
gel pack


USAGE: For Research Use Only! Not For Use in Humans
















K262 :: Nitric Oxide Colorimetric
Assay Kit
• Atochin, D. et al.
Soluble Guanylate Cyclase
a• 1β1 Limits Stoke
Size and Attenuates Neurological Injury. Stroke, 2010; 41:
1815-1819.
• Caretti A et al
(2008) Experimental Biology and Medicine 233: 1222-1230.
• Kim, H. W. et. al. Long-term blockade of
vascular endothelial growth factor receptor-2 aggravates the diabetic renal
dysfunction associated with inactivation of the Akt/eNOS-NO axis. Nephrol.
Dial. Transplant., Apr 2011; 26: 1173 -
1188.
• Wang, X. P. et. al. Arginase I
Attenuates Inflammatory Cytokine Secretion Induced by Lipopolysaccharide in
Vascular Smooth Muscle Cells. Arterioscler
Thromb Vasc Biol, Aug 2011; 31: 1853 - 1860.
• Wang, X. P. et. al. Arginase I Attenuates Inflammatory
Cytokine Secretion Induced by Lipopolysaccharide in Vascular Smooth Muscle
Cells. Arterioscler
Thromb Vasc Biol, Aug 2011; 31: 1853 - 1860.
arrow
arrow
    全站熱搜

    太鼎生物科技 發表在 痞客邦 留言(0) 人氣()